Font Size: a A A
Keyword [Transarterial Chemoembolization]
Result: 121 - 140 | Page: 7 of 9
121. Efficacy And Safety Of Drug-eluting Beads In The Treatment Of Large Hepatocellular Carcinoma
122. Application Of New Lipiodol Pickering Emulsion In Interventional Therapy Of Liver Cancer
123. Combination Of Bronchial Arterial Infusion Chemotherapy Plus Drug-eluting Bead Transarterial Chemoembolization For Treatment Of Advanced Lung Cancer
124. The Short-term Efficacy And Safety Study Of CalliSpheres~? Drug-Eluting Beads Combined With Lipiodol Transarterial Chemoembolization In The Treatment Of Large Liver Cancer
125. Survival Benfit Fo Transarterial Chemoembolization Combined With Endovascular Implant Iodin-125 Seed Versus Transarterial Chemoembolization Combined With External Radiotherapy For The Inoperable Patient Of The Hepatocellular Carcinoma With Portal Vein Tum
126. Feasibility And Clinical Efficacy Analysis Of Transarterial Chemoembolization Combined With Radiofrequency Ablation For The Treatment Of Hepatocellular Carcinoma Involved The Second Hepatic Hilar Region
127. TACE Plus Sorafenib Versus TACE Alone In Treatment Of BCLC-B Hepatocellular Carcinoma:A Prospective,Multicenter,Controlled Study
128. The Clinical Efficacy Of Transarterial Chemoembolization Combined With Anlotinib In The Treatment Of Advanced Hepatocellular Carcinoma
129. Preliminary Clinical Study On Drug Eluting Beads Transarterial Chemoembolization For The Treatment Of Unresectable Colorectal Liver Metastases
130. The Clinical Research Of Hepatocellular Carcinoma Treated With CalliSpheres Drug-eluting Beads Transarterial Chemoembolization
131. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model
132. Radiomics Analysis Based On Contrast-enhanced MRI For Prediction Of The Early Therapeutic Response To Transarterial Chemoembolization In Hepatocellular Carcinoma
133. Genetic Analysis Of Prognosis And Complications Of Hepatocellular Carcinoma Patients Receiving Tace After Hepatoectomy
134. A Series Of Clinical Researches On Early Prediction Of TACE Refractoriness Hepatocarcinoma And The Preliminary Analysis Of The Treatment For TACE Refractoriness
135. Analysis Of Prognostic Factors In HBV-related Primary Liver Cancer After Transarterial Chemoembolization
136. Analysis Of Prognostic Factors After TACE By Baseline Datas Of HBV-associated Primary Liver Cancer Patients
137. Application Value Of C-arm Computed Tomography Parenchymal Blood Volume(C-arm CT-PBV) Perfusion Imaging In The Evaluation Of Transarterial Chemoembolization Of Hepatocellular Carcinoma
138. Prediction Of C-TACE Response And Prognosis In Intermediate-stage Hepatocellular Carcinoma Based On Quantitative CT Parameters
139. Efficacy Evaluation And Development Of Prognostic Nomogram For Patients With Hepatocellular Carcinoma Treated With Drug-eluting Bead Transarterial Chemoembolization
140. Clinical Efficacy And Prognostic Factors Of Different Treatment Methods For Stage B Hepatocellular Carcinoma In Barcelona
  <<First  <Prev  Next>  Last>>  Jump to